Techno Trends
Techno Trends includes advancements and innovations in pharmaceutical products and technology from around the world. Additionally, you may keep abreast of any recent advancements in the pharmaceutical industry (product information and technological trends).
Osteal Therapeutics VT-X7 Receives FDA Breakthrough Designation
The Breakthrough Therapy Designation has been granted by the U.S. Food and Drug Administration for VT-X7, an investigational drug therapy developed by Osteal Therapeutics. This designation is bestowed upon drugs...
Nectero EAST® System Received Breakthrough Therapy Designation for Innovative Approach in Infrarenal AAA Treatment
Nectero Medical, a leading clinical-stage biotechnology firm dedicated to advancing therapies for aneurysmal diseases, has announced that the U.S. Food and Drug Administration...
Roche's novel Elecsys NfL test secures FDA Breakthrough Device Designation for multiple sclerosis
Roche has recently announced that its Elecsys® Neurofilament Light Chain (NfL) test, developed for multiple sclerosis has received Breakthrough Device Designation from the U.S. Food and Drug Administration...
BioPhy's Novel AI Platform to Propel Growth in the Trillion-Dollar Drug Development Sector
BioPhy has introduced an innovative AI operating system aimed at significantly expediting the identification and development of promising drug candidates....
FDA Approves First-of-Its-Kind PENBRAYA™ Vaccine for Top 5 Meningococcal Strains in Adolescents
Pfizer has announced the FDA's approval of PENBRAYA™, an innovative pentavalent vaccine. PENBRAYA™ is the first and only vaccine designed to safeguard adolescents and young adults, aged 10 to 25...
Tiziana Life Sciences Granted FDA Breakthrough Approval for At-Home Intranasal Foralumab in Multiple Sclerosis Treatment
Tiziana Life Sciences, a biotechnology company specializing in innovative immunomodulation therapies, has reached a significant milestone in the treatment of multiple sclerosis. The U.S. Food and Drug Administration...
Novel MicroRNA Therapy Shows Great Potential in Delaying Cancer Tumor Progression
Researchers at Purdue University have devised an innovative cancer therapy that employs a unique approach to impede the growth of tumors. This method tricks cancer cells into absorbing a fragment of RNA, which naturally hampers their ability to divide....
Citius Pharmaceuticals Receives Novel FDA Complete Response Letter for LYMPHIR™ in Cutaneous T-Cell Lymphoma
Citius Pharmaceuticals, has shared a significant update regarding the progress of their product denileukin diftitox ("LYMPHIRTM") through the FDA approval process. The U.S. Food and Drug Administration (FDA) has issued a Complete Response Letter in response to the Company's application seeking approval for LYMPHIRTM....
Ipsen's Sohonos™ Capsules Granted FDA Approval as a Novel Treatment for Fibrodysplasia Ossificans Progressiva
Ipsen has officially received approval from the U.S. Food and Drug Administration (FDA) for Sohonos™ (palovarotene) capsules....
ELREXFIO™ by Pfizer Breaks Ground with Accelerated FDA Approval to Tackle Relapsed or Refractory Multiple Myeloma
Pfizer has just received accelerated approval from the U.S. Food and Drug Administration (FDA) for its ELREXFIO™ (elranatamab-bcmm) to treat adult patients dealing with relapsed or refractory multiple myeloma (RRMM)....
